title: Osteonecrosis of the tibia associated with imatinib in metastatic GI stromal tumor.
authors.affiliation: Department of General Surgery, Chang Gung Memorial Hospital, #5 Fu-Hsing St, Kwei-Shan, Taoyuan, Taiwan. yehchunnan@gmail.com
authors.forename: Chun-Nan
authors.initials: CN
authors.lastname: Yeh
authors.forename: Chen-Ju
authors.initials: CJ
authors.lastname: Fu
authors.forename: Tzu-Chen
authors.initials: TC
authors.lastname: Yen
authors.forename: Kun-Chun
authors.initials: KC
authors.lastname: Chiang
authors.forename: Yi-Yin
authors.initials: YY
authors.lastname: Jan
authors.forename: Miin-Fu
authors.initials: MF
authors.lastname: Chen
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001549:Benzamides / Q000008:administration & dosage / Q000009:adverse effects*; D018450:Disease Progression; D004334:Drug Administration Schedule; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D046152:Gastrointestinal Stromal Tumors / Q000175:diagnosis / Q000188:drug therapy* / Q000556:secondary; D006801:Humans; D000068877:Imatinib Mesylate; D033162:Incidental Findings; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008875:Middle Aged; D010020:Osteonecrosis / Q000139:chemically induced* / Q000150:complications; D010146:Pain / Q000209:etiology; D010534:Peritoneal Neoplasms / Q000188:drug therapy* / Q000556:secondary; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects*; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects*; D016059:Range of Motion, Articular; D013977:Tibia / Q000187:drug effects* / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate